nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—Gemfibrozil—coronary artery disease	0.264	0.594	CrCtD
Bupranolol—Timolol—coronary artery disease	0.0979	0.22	CrCtD
Bupranolol—ADRB1—coronary artery disease	0.0836	0.543	CbGaD
Bupranolol—Penbutolol—coronary artery disease	0.0832	0.187	CrCtD
Bupranolol—ADRB2—coronary artery disease	0.0703	0.457	CbGaD
Bupranolol—Timolol—Penbutolol—coronary artery disease	0.0641	0.295	CrCrCtD
Bupranolol—ADRB3—Timolol—coronary artery disease	0.0528	0.338	CbGbCtD
Bupranolol—Levobunolol—Timolol—coronary artery disease	0.0344	0.158	CrCrCtD
Bupranolol—Penbutolol—Timolol—coronary artery disease	0.0313	0.144	CrCrCtD
Bupranolol—ADRB2—Penbutolol—coronary artery disease	0.0306	0.196	CbGbCtD
Bupranolol—ADRB1—Penbutolol—coronary artery disease	0.0302	0.193	CbGbCtD
Bupranolol—Carteolol—Penbutolol—coronary artery disease	0.0292	0.134	CrCrCtD
Bupranolol—Nadolol—Penbutolol—coronary artery disease	0.0292	0.134	CrCrCtD
Bupranolol—Levobunolol—Penbutolol—coronary artery disease	0.0292	0.134	CrCrCtD
Bupranolol—ADRB2—Timolol—coronary artery disease	0.0216	0.138	CbGbCtD
Bupranolol—ADRB1—Timolol—coronary artery disease	0.0213	0.136	CbGbCtD
Bupranolol—Pirbuterol—ADRB1—coronary artery disease	0.000113	0.0632	CrCbGaD
Bupranolol—Gemfibrozil—CYP2C19—coronary artery disease	0.000101	0.0567	CrCbGaD
Bupranolol—Levobunolol—ADRB1—coronary artery disease	0.000101	0.0563	CrCbGaD
Bupranolol—Timolol—ADRB1—coronary artery disease	9.61e-05	0.0537	CrCbGaD
Bupranolol—Pirbuterol—ADRB2—coronary artery disease	9.5e-05	0.0531	CrCbGaD
Bupranolol—Carteolol—ADRB1—coronary artery disease	8.56e-05	0.0479	CrCbGaD
Bupranolol—Levobunolol—ADRB2—coronary artery disease	8.47e-05	0.0474	CrCbGaD
Bupranolol—Timolol—ADRB2—coronary artery disease	8.08e-05	0.0452	CrCbGaD
Bupranolol—Terbutaline—ADRB2—coronary artery disease	7.75e-05	0.0433	CrCbGaD
Bupranolol—Nadolol—ADRB1—coronary artery disease	7.63e-05	0.0427	CrCbGaD
Bupranolol—Clenbuterol—ADRB1—coronary artery disease	7.36e-05	0.0412	CrCbGaD
Bupranolol—Carteolol—ADRB2—coronary artery disease	7.2e-05	0.0403	CrCbGaD
Bupranolol—Clenbuterol—TNF—coronary artery disease	6.99e-05	0.0391	CrCbGaD
Bupranolol—Bopindolol—ADRB1—coronary artery disease	6.98e-05	0.039	CrCbGaD
Bupranolol—Timolol—CYP2C19—coronary artery disease	6.96e-05	0.0389	CrCbGaD
Bupranolol—Salbutamol—ADRB1—coronary artery disease	6.85e-05	0.0383	CrCbGaD
Bupranolol—Penbutolol—ADRB1—coronary artery disease	6.66e-05	0.0372	CrCbGaD
Bupranolol—Nadolol—ADRB2—coronary artery disease	6.42e-05	0.0359	CrCbGaD
Bupranolol—Clenbuterol—ADRB2—coronary artery disease	6.19e-05	0.0346	CrCbGaD
Bupranolol—Bopindolol—ADRB2—coronary artery disease	5.87e-05	0.0328	CrCbGaD
Bupranolol—Salbutamol—ADRB2—coronary artery disease	5.76e-05	0.0322	CrCbGaD
Bupranolol—Penbutolol—ADRB2—coronary artery disease	5.6e-05	0.0313	CrCbGaD
Bupranolol—Pindolol—ADRB1—coronary artery disease	4.8e-05	0.0268	CrCbGaD
Bupranolol—Pindolol—ADRB2—coronary artery disease	4.04e-05	0.0226	CrCbGaD
Bupranolol—ADRB1—GPCR downstream signaling—AGT—coronary artery disease	4.4e-06	0.000177	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOC3—coronary artery disease	4.4e-06	0.000176	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCL8—coronary artery disease	4.38e-06	0.000176	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PPP2CA—coronary artery disease	4.38e-06	0.000176	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—LDLR—coronary artery disease	4.37e-06	0.000175	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL3—coronary artery disease	4.36e-06	0.000175	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL2—coronary artery disease	4.36e-06	0.000175	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PPP2CA—coronary artery disease	4.36e-06	0.000175	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SDC1—coronary artery disease	4.31e-06	0.000173	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—F2R—coronary artery disease	4.31e-06	0.000173	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AGT—coronary artery disease	4.31e-06	0.000173	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PRKCD—coronary artery disease	4.3e-06	0.000173	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PPP2CA—coronary artery disease	4.29e-06	0.000172	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PRKCD—coronary artery disease	4.28e-06	0.000172	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL2—coronary artery disease	4.27e-06	0.000171	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL3—coronary artery disease	4.27e-06	0.000171	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FGB—coronary artery disease	4.22e-06	0.000169	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SDC1—coronary artery disease	4.22e-06	0.000169	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—F2R—coronary artery disease	4.22e-06	0.000169	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR2A—coronary artery disease	4.21e-06	0.000169	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PRKCD—coronary artery disease	4.21e-06	0.000169	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—C3—coronary artery disease	4.21e-06	0.000169	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR2A—coronary artery disease	4.19e-06	0.000168	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—C3—coronary artery disease	4.19e-06	0.000168	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EDNRB—coronary artery disease	4.18e-06	0.000168	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FGB—coronary artery disease	4.13e-06	0.000166	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR2A—coronary artery disease	4.12e-06	0.000165	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—THBS1—coronary artery disease	4.12e-06	0.000165	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—C3—coronary artery disease	4.11e-06	0.000165	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EDNRB—coronary artery disease	4.09e-06	0.000164	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PSMB5—coronary artery disease	4.08e-06	0.000164	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PSMA6—coronary artery disease	4.08e-06	0.000164	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—F2—coronary artery disease	4.07e-06	0.000163	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—THBS1—coronary artery disease	4.03e-06	0.000162	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AGT—coronary artery disease	4e-06	0.00016	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HIF1A—coronary artery disease	3.99e-06	0.00016	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PSMB5—coronary artery disease	3.99e-06	0.00016	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PSMA6—coronary artery disease	3.99e-06	0.00016	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—F2—coronary artery disease	3.98e-06	0.00016	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AGT—coronary artery disease	3.98e-06	0.00016	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EDNRA—coronary artery disease	3.95e-06	0.000158	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CYBA—coronary artery disease	3.93e-06	0.000158	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DUSP6—coronary artery disease	3.91e-06	0.000157	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AGT—coronary artery disease	3.91e-06	0.000157	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—LEP—coronary artery disease	3.9e-06	0.000156	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—APOE—coronary artery disease	3.9e-06	0.000156	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EDNRA—coronary artery disease	3.86e-06	0.000155	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—APOA1—coronary artery disease	3.85e-06	0.000155	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PLAT—coronary artery disease	3.85e-06	0.000154	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADRB1—coronary artery disease	3.84e-06	0.000154	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CYBA—coronary artery disease	3.84e-06	0.000154	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DUSP6—coronary artery disease	3.83e-06	0.000154	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—KDR—coronary artery disease	3.82e-06	0.000153	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAPK14—coronary artery disease	3.79e-06	0.000152	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PLAT—coronary artery disease	3.76e-06	0.000151	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ESR1—coronary artery disease	3.72e-06	0.000149	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL12—coronary artery disease	3.71e-06	0.000149	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—BDKRB2—coronary artery disease	3.71e-06	0.000149	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—POMC—coronary artery disease	3.7e-06	0.000149	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—F2—coronary artery disease	3.69e-06	0.000148	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6ST—coronary artery disease	3.68e-06	0.000148	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—F2—coronary artery disease	3.68e-06	0.000148	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FN1—coronary artery disease	3.68e-06	0.000148	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6ST—coronary artery disease	3.66e-06	0.000147	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—JUNB—coronary artery disease	3.64e-06	0.000146	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NFKBIA—coronary artery disease	3.63e-06	0.000146	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL12—coronary artery disease	3.63e-06	0.000146	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—BDKRB2—coronary artery disease	3.63e-06	0.000146	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PLCB1—coronary artery disease	3.63e-06	0.000146	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—POMC—coronary artery disease	3.62e-06	0.000145	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—F2—coronary artery disease	3.61e-06	0.000145	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6ST—coronary artery disease	3.6e-06	0.000144	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—JUNB—coronary artery disease	3.56e-06	0.000143	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR7—coronary artery disease	3.55e-06	0.000143	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PLCB1—coronary artery disease	3.55e-06	0.000142	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—KIT—coronary artery disease	3.52e-06	0.000141	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR7—coronary artery disease	3.48e-06	0.00014	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ITGAV—coronary artery disease	3.39e-06	0.000136	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GSK3B—coronary artery disease	3.38e-06	0.000135	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KNG1—coronary artery disease	3.38e-06	0.000135	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—POMC—coronary artery disease	3.36e-06	0.000135	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CREB1—coronary artery disease	3.36e-06	0.000135	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AGTR1—coronary artery disease	3.35e-06	0.000135	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—POMC—coronary artery disease	3.35e-06	0.000134	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CREB1—coronary artery disease	3.35e-06	0.000134	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ITGAV—coronary artery disease	3.31e-06	0.000133	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KNG1—coronary artery disease	3.3e-06	0.000133	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CCL2—coronary artery disease	3.29e-06	0.000132	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—POMC—coronary artery disease	3.29e-06	0.000132	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CREB1—coronary artery disease	3.29e-06	0.000132	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AGTR1—coronary artery disease	3.28e-06	0.000132	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6R—coronary artery disease	3.28e-06	0.000132	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL10—coronary artery disease	3.28e-06	0.000132	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCL2—coronary artery disease	3.28e-06	0.000132	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PLG—coronary artery disease	3.27e-06	0.000131	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6R—coronary artery disease	3.27e-06	0.000131	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IGF1—coronary artery disease	3.22e-06	0.000129	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CCL2—coronary artery disease	3.22e-06	0.000129	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6R—coronary artery disease	3.21e-06	0.000129	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL10—coronary artery disease	3.21e-06	0.000129	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—MAPK1—coronary artery disease	3.21e-06	0.000129	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PLG—coronary artery disease	3.2e-06	0.000128	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADRB2—coronary artery disease	3.18e-06	0.000128	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRKCE—coronary artery disease	3.14e-06	0.000126	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—JAK2—coronary artery disease	3.14e-06	0.000126	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SOCS1—coronary artery disease	3.13e-06	0.000126	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—S100B—coronary artery disease	3.13e-06	0.000126	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SOCS3—coronary artery disease	3.1e-06	0.000124	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRKCE—coronary artery disease	3.07e-06	0.000123	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—JAK2—coronary artery disease	3.07e-06	0.000123	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SOCS1—coronary artery disease	3.07e-06	0.000123	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—PIK3CA—coronary artery disease	3.06e-06	0.000123	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KITLG—coronary artery disease	3.06e-06	0.000123	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TGFBR2—coronary artery disease	3.06e-06	0.000123	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—S100B—coronary artery disease	3.06e-06	0.000123	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SERPINE1—coronary artery disease	3.06e-06	0.000123	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SOCS3—coronary artery disease	3.03e-06	0.000122	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KITLG—coronary artery disease	2.99e-06	0.00012	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TGFBR2—coronary artery disease	2.99e-06	0.00012	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MMP3—coronary artery disease	2.99e-06	0.00012	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—STAT5A—coronary artery disease	2.99e-06	0.00012	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FGF2—coronary artery disease	2.96e-06	0.000119	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MMP3—coronary artery disease	2.93e-06	0.000117	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—STAT5A—coronary artery disease	2.93e-06	0.000117	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NOS3—coronary artery disease	2.92e-06	0.000117	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APOB—coronary artery disease	2.89e-06	0.000116	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCL8—coronary artery disease	2.87e-06	0.000115	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—JAK2—coronary artery disease	2.85e-06	0.000114	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EDN1—coronary artery disease	2.84e-06	0.000114	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—JAK2—coronary artery disease	2.84e-06	0.000114	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOB—coronary artery disease	2.83e-06	0.000114	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL5—coronary artery disease	2.82e-06	0.000113	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCL8—coronary artery disease	2.8e-06	0.000113	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—JAK2—coronary artery disease	2.79e-06	0.000112	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EDN1—coronary artery disease	2.78e-06	0.000112	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PIK3CA—coronary artery disease	2.78e-06	0.000112	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CSF2—coronary artery disease	2.78e-06	0.000112	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FGF1—coronary artery disease	2.78e-06	0.000112	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL5—coronary artery disease	2.76e-06	0.000111	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—LPL—coronary artery disease	2.76e-06	0.000111	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RPS6KB1—coronary artery disease	2.73e-06	0.00011	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MEF2C—coronary artery disease	2.73e-06	0.00011	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CSF2—coronary artery disease	2.72e-06	0.000109	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FGF1—coronary artery disease	2.72e-06	0.000109	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—LPL—coronary artery disease	2.7e-06	0.000108	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RPS6KB1—coronary artery disease	2.68e-06	0.000107	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MEF2C—coronary artery disease	2.68e-06	0.000107	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ITGB3—coronary artery disease	2.67e-06	0.000107	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ITGB3—coronary artery disease	2.61e-06	0.000105	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCL8—coronary artery disease	2.6e-06	0.000104	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCL8—coronary artery disease	2.59e-06	0.000104	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PPP2CA—coronary artery disease	2.59e-06	0.000104	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCL8—coronary artery disease	2.55e-06	0.000102	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRKCD—coronary artery disease	2.54e-06	0.000102	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PPP2CA—coronary artery disease	2.53e-06	0.000102	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—AKT1—coronary artery disease	2.5e-06	0.0001	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR2A—coronary artery disease	2.49e-06	9.99e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRKCD—coronary artery disease	2.49e-06	9.99e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—C3—coronary artery disease	2.48e-06	9.98e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CASP3—coronary artery disease	2.48e-06	9.95e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL6—coronary artery disease	2.46e-06	9.89e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR2A—coronary artery disease	2.43e-06	9.77e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—C3—coronary artery disease	2.43e-06	9.76e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CCND1—coronary artery disease	2.41e-06	9.69e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HIF1A—coronary artery disease	2.37e-06	9.51e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AGT—coronary artery disease	2.36e-06	9.48e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MMP9—coronary artery disease	2.34e-06	9.4e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HIF1A—coronary artery disease	2.32e-06	9.31e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—LEP—coronary artery disease	2.31e-06	9.29e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APOE—coronary artery disease	2.31e-06	9.29e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AGT—coronary artery disease	2.31e-06	9.27e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APOA1—coronary artery disease	2.29e-06	9.18e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—AKT1—coronary artery disease	2.27e-06	9.12e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KDR—coronary artery disease	2.27e-06	9.1e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—LEP—coronary artery disease	2.26e-06	9.08e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOE—coronary artery disease	2.26e-06	9.08e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAPK14—coronary artery disease	2.25e-06	9.04e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOA1—coronary artery disease	2.24e-06	8.98e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KDR—coronary artery disease	2.22e-06	8.9e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ESR1—coronary artery disease	2.21e-06	8.87e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAPK14—coronary artery disease	2.2e-06	8.84e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—F2—coronary artery disease	2.18e-06	8.76e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FN1—coronary artery disease	2.18e-06	8.76e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6ST—coronary artery disease	2.17e-06	8.72e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ESR1—coronary artery disease	2.16e-06	8.67e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NFKBIA—coronary artery disease	2.16e-06	8.65e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—F2—coronary artery disease	2.13e-06	8.57e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FN1—coronary artery disease	2.13e-06	8.57e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6ST—coronary artery disease	2.13e-06	8.53e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NFKBIA—coronary artery disease	2.11e-06	8.47e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—VEGFA—coronary artery disease	2.1e-06	8.44e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KIT—coronary artery disease	2.09e-06	8.38e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KIT—coronary artery disease	2.04e-06	8.2e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GSK3B—coronary artery disease	2e-06	8.04e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—POMC—coronary artery disease	1.99e-06	7.98e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CREB1—coronary artery disease	1.99e-06	7.98e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GSK3B—coronary artery disease	1.96e-06	7.87e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCL2—coronary artery disease	1.94e-06	7.81e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—POMC—coronary artery disease	1.94e-06	7.8e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CREB1—coronary artery disease	1.94e-06	7.8e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6R—coronary artery disease	1.94e-06	7.78e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TGFB1—coronary artery disease	1.93e-06	7.75e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IGF1—coronary artery disease	1.91e-06	7.67e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—MAPK1—coronary artery disease	1.9e-06	7.64e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCL2—coronary artery disease	1.9e-06	7.64e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6R—coronary artery disease	1.9e-06	7.61e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAPK1—coronary artery disease	1.89e-06	7.6e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IGF1—coronary artery disease	1.87e-06	7.51e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—MAPK1—coronary artery disease	1.86e-06	7.47e-05	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.82e-06	7.3e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SERPINE1—coronary artery disease	1.82e-06	7.29e-05	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.78e-06	7.14e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SERPINE1—coronary artery disease	1.78e-06	7.13e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FGF2—coronary artery disease	1.76e-06	7.05e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NOS3—coronary artery disease	1.73e-06	6.96e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FGF2—coronary artery disease	1.72e-06	6.9e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NOS3—coronary artery disease	1.7e-06	6.81e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—JAK2—coronary artery disease	1.68e-06	6.76e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	1.65e-06	6.63e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—JAK2—coronary artery disease	1.65e-06	6.61e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PIK3CA—coronary artery disease	1.64e-06	6.6e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	1.61e-06	6.48e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	1.54e-06	6.17e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	1.5e-06	6.04e-05	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	1.48e-06	5.96e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CASP3—coronary artery disease	1.47e-06	5.91e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6—coronary artery disease	1.46e-06	5.87e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6—coronary artery disease	1.45e-06	5.84e-05	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	1.45e-06	5.83e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CASP3—coronary artery disease	1.44e-06	5.78e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CCND1—coronary artery disease	1.43e-06	5.75e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6—coronary artery disease	1.43e-06	5.74e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CCND1—coronary artery disease	1.4e-06	5.62e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MMP9—coronary artery disease	1.39e-06	5.58e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MMP9—coronary artery disease	1.36e-06	5.46e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	1.35e-06	5.41e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AKT1—coronary artery disease	1.34e-06	5.39e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	1.32e-06	5.3e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	1.25e-06	5.01e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	1.22e-06	4.9e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	1.15e-06	4.6e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	1.12e-06	4.51e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	1.12e-06	4.5e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	1.1e-06	4.41e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	9.75e-07	3.91e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	9.54e-07	3.83e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6—coronary artery disease	8.64e-07	3.47e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6—coronary artery disease	8.45e-07	3.39e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AKT1—coronary artery disease	7.97e-07	3.2e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AKT1—coronary artery disease	7.79e-07	3.13e-05	CbGpPWpGaD
